Vitro Biopharma, Inc. Quarterly Revenues in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Vitro Biopharma, Inc. quarterly/annual Revenues history and growth rate from Q4 2013 to Q2 2024.
  • Vitro Biopharma, Inc. Revenues for the quarter ending July 31, 2024 was $320K, a 44.6% decline year-over-year.
  • Vitro Biopharma, Inc. annual Revenues for 2015 was $77.8K, a 35% decline from 2014.
  • Vitro Biopharma, Inc. annual Revenues for 2014 was $120K, a 422% increase from 2013.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $320K -$257K -44.6% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $573K +$265K +86.1% Feb 1, 2024 Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $424K +$80.2K +23.3% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-14
Q2 2023 $577K May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $308K Feb 1, 2023 Apr 30, 2023 10-Q 2024-05-31
Q4 2022 $344K -$812K -70.2% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-14
Q4 2021 $1.16M Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
Q1 2015 $20.4K -$7.21K -26.1% Feb 1, 2015 Apr 30, 2015 10-Q 2016-01-22
Q4 2014 $14.5K -$10.2K -41.3% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-24
Q1 2014 $27.6K Feb 1, 2014 Apr 30, 2014 10-Q 2016-01-22
Q4 2013 $24.7K Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.